Trial · NCT03347422
Adverse events775
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 775
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 6.5 g | 0 | 17 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 7.5 g | 2 | 5 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Part A: Placebo | 0 | 20 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 6.5 g | 9 | 32 | 11 |
| other | Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 7.5 g | 2 | 7 | 3 |
| other | Blood Loss Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 6.5 g | 1 | 17 | 1 |
| other | Blood Loss Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 7.5 g | 0 | 5 | 0 |
| other | Blood Loss Anaemia | Blood and lymphatic system disorders | Part A: Placebo | 0 | 20 | 0 |
| other | Blood Loss Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 6.5 g | 0 | 32 | 0 |
| other | Blood Loss Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 7.5 g | 0 | 7 | 0 |
| other | Haemolysis | Blood and lymphatic system disorders | Part A: BIVV009 6.5 g | 0 | 17 | 0 |
| other | Haemolysis | Blood and lymphatic system disorders | Part A: BIVV009 7.5 g | 0 | 5 | 0 |
| other | Haemolysis | Blood and lymphatic system disorders | Part A: Placebo | 0 | 20 | 0 |
| other | Haemolysis | Blood and lymphatic system disorders | Part B: BIVV009 6.5 g | 2 | 32 | 2 |
| other | Haemolysis | Blood and lymphatic system disorders | Part B: BIVV009 7.5 g | 0 | 7 | 0 |
| other | Iron Deficiency Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 6.5 g | 0 | 17 | 0 |
| other | Iron Deficiency Anaemia | Blood and lymphatic system disorders | Part A: BIVV009 7.5 g | 0 | 5 | 0 |
| other | Iron Deficiency Anaemia | Blood and lymphatic system disorders | Part A: Placebo | 0 | 20 | 0 |
| other | Iron Deficiency Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 6.5 g | 3 | 32 | 4 |
| other | Iron Deficiency Anaemia | Blood and lymphatic system disorders | Part B: BIVV009 7.5 g | 1 | 7 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03347422/events